treatments epilepsy neuropsychiatric disorders

Mindful Innovation

Bringing Hope to Patients

Developing new treatments to improve the lives of patients and families affected by epilepsy and neuropsychiatric disorders.
Our Pledge to Patients

 

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings.

Our Science & Pipeline
 
post partum depression indications

Status Epilepticus

Striving To Maintain Seizure Control

Developing therapies with the potential to provide rapid cessation of status and prevent escalation of treatment

Learn More
 

Pediatric Orphan Epilepsies

Aspiring to Give Children Seizure-Free Days

Ganaxolone offers the potential to safely decrease seizure frequency in children with refractory epilepsy.

Learn More
 

WHY WE WORK

To make a difference in the lives of patients and their families.

  • ARTWORK BY AVA This artwork was mabe by young Ava.
  • KIERA
  • AMANDA
  • VIOLET
  • ARTWORK BY G
  • SLOAN
normal healthy girl father

FOLLOW US ON TWITTER

Cleveland movers
Cleveland movers